420 related articles for article (PubMed ID: 25657126)
1. Biofilm as a virulence marker in Candida species in Nosocomial blood stream infection and its correlation with antifungal resistance.
Bhatt M; Sarangi G; Paty BP; Mohapatra D; Chayani N; Mahapatra A; Das P; Sahoo D
Indian J Med Microbiol; 2015 Feb; 33 Suppl():112-4. PubMed ID: 25657126
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. [Investigation of antifungal susceptibilities and some virulence factors of Candida strains isolated from blood cultures and genotyping by RAPD-PCR].
Gültekin B; Eyigör M; Tiryaki Y; Kırdar S; Aydın N
Mikrobiyol Bul; 2011 Apr; 45(2):306-17. PubMed ID: 21644074
[TBL] [Abstract][Full Text] [Related]
4. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
[TBL] [Abstract][Full Text] [Related]
5. Yeasts isolated from nosocomial urinary infections: antifungal susceptibility and biofilm production.
de Freitas AR; Baeza LC; Faria MG; Dota KF; Godoy Martínez P; Svidzinski TI
Rev Iberoam Micol; 2014; 31(2):104-8. PubMed ID: 23810785
[TBL] [Abstract][Full Text] [Related]
6. Role of Non Albicans Candida Spp. and Biofilm in Neonatal ICU.
Goel S; Mittal S; Chaudhary U
Infect Disord Drug Targets; 2016; 16(3):192-198. PubMed ID: 27538491
[TBL] [Abstract][Full Text] [Related]
7. [In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints].
Calışkan S; Keçeli Özcan S; Cınar S; Corakçı A; Calışkan E
Mikrobiyol Bul; 2011 Oct; 45(4):697-706. PubMed ID: 22090300
[TBL] [Abstract][Full Text] [Related]
8. Candidemia by species of the Candida parapsilosis complex in children's hospital: prevalence, biofilm production and antifungal susceptibility.
Ruiz LS; Khouri S; Hahn RC; da Silva EG; de Oliveira VK; Gandra RF; Paula CR
Mycopathologia; 2013 Apr; 175(3-4):231-9. PubMed ID: 23404576
[TBL] [Abstract][Full Text] [Related]
9. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities.
Wisplinghoff H; Ebbers J; Geurtz L; Stefanik D; Major Y; Edmond MB; Wenzel RP; Seifert H
Int J Antimicrob Agents; 2014 Jan; 43(1):78-81. PubMed ID: 24182454
[TBL] [Abstract][Full Text] [Related]
10. Antifungal susceptibility and virulence determinants profile of candida species isolated from patients with candidemia.
Dawoud AM; Saied SA; Torayah MM; Ramadan AE; Elaskary SA
Sci Rep; 2024 May; 14(1):11597. PubMed ID: 38773138
[TBL] [Abstract][Full Text] [Related]
11. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis.
Pinto PM; Weikert-Oliveira Rde C; Lyon JP; Cury VF; Arantes RR; Koga-Ito CY; Resende MA
Microbiol Res; 2008; 163(5):579-85. PubMed ID: 16962755
[TBL] [Abstract][Full Text] [Related]
12. [Antifungal susceptibility of Candida spp. isolates from blood cultures in a five-year period (1997-2001)].
Durán MT; Velasco D; Canle D; Moure R; Villanueva R
Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):488-92. PubMed ID: 14572381
[TBL] [Abstract][Full Text] [Related]
13. Species distribution and antifungal susceptibility profile of Candida spp. bloodstream isolates from Latin American hospitals.
Godoy P; Tiraboschi IN; Severo LC; Bustamante B; Calvo B; Almeida LP; da Matta DA; Colombo AL
Mem Inst Oswaldo Cruz; 2003 Apr; 98(3):401-5. PubMed ID: 12886424
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of candidemia in a Turkish tertiary care hospital.
Bakir M; Cerikcioglu N; Barton R; Yagci A
APMIS; 2006 Sep; 114(9):601-10. PubMed ID: 16948812
[TBL] [Abstract][Full Text] [Related]
15. Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex.
Melo AS; Bizerra FC; Freymüller E; Arthington-Skaggs BA; Colombo AL
Med Mycol; 2011 Apr; 49(3):253-62. PubMed ID: 21039308
[TBL] [Abstract][Full Text] [Related]
16. Candidemia and the susceptibility pattern of Candida isolates in blood.
Osoba AO; Al-Mowallad AW; McAlear DE; Hussein BA
Saudi Med J; 2003 Oct; 24(10):1060-3. PubMed ID: 14578968
[TBL] [Abstract][Full Text] [Related]
17. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.
Ozhak-Baysan B; Ogunc D; Colak D; Ongut G; Donmez L; Vural T; Gunseren F
Med Mycol; 2012 Jul; 50(5):529-32. PubMed ID: 21988703
[TBL] [Abstract][Full Text] [Related]
18. [Epidemiological and microbiological evaluation of nosocomial infections caused by Candida species].
Erdem F; Tuncer Ertem G; Oral B; Karakoç E; Demiröz AP; Tülek N
Mikrobiyol Bul; 2012 Oct; 46(4):637-48. PubMed ID: 23188577
[TBL] [Abstract][Full Text] [Related]
19. [Biofilm production and antifungal susceptibility patterns of Candida species].
Yücesoy M; Karaman M
Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
[TBL] [Abstract][Full Text] [Related]
20. Anti-fungal susceptibility and virulence factors of Candida spp. isolated from blood cultures.
Sriphannam C; Nuanmuang N; Saengsawang K; Amornthipayawong D; Kummasook A
J Mycol Med; 2019 Dec; 29(4):325-330. PubMed ID: 31447236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
